Autonomix Medical (AMIX) Competitors $1.42 -0.01 (-0.70%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$1.38 -0.04 (-2.61%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMIX vs. MHUA, LYRA, INBS, WOK, DHAI, SSKN, PAVM, BTCY, CODX, and NUROShould you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include Meihua International Medical Technologies (MHUA), Lyra Therapeutics (LYRA), Intelligent Bio Solutions (INBS), WORK Medical Technology Group (WOK), DIH Holding US (DHAI), Strata Skin Sciences (SSKN), PAVmed (PAVM), Biotricity (BTCY), Co-Diagnostics (CODX), and NeuroMetrix (NURO). These companies are all part of the "medical equipment" industry. Autonomix Medical vs. Its Competitors Meihua International Medical Technologies Lyra Therapeutics Intelligent Bio Solutions WORK Medical Technology Group DIH Holding US Strata Skin Sciences PAVmed Biotricity Co-Diagnostics NeuroMetrix Autonomix Medical (NASDAQ:AMIX) and Meihua International Medical Technologies (NASDAQ:MHUA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership. Do institutionals and insiders have more ownership in AMIX or MHUA? 10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 1.2% of Meihua International Medical Technologies shares are held by institutional investors. 32.4% of Autonomix Medical shares are held by insiders. Comparatively, 66.6% of Meihua International Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer AMIX or MHUA? In the previous week, Autonomix Medical and Autonomix Medical both had 1 articles in the media. Autonomix Medical's average media sentiment score of 1.89 beat Meihua International Medical Technologies' score of 1.87 indicating that Autonomix Medical is being referred to more favorably in the media. Company Overall Sentiment Autonomix Medical Very Positive Meihua International Medical Technologies Very Positive Is AMIX or MHUA more profitable? Meihua International Medical Technologies' return on equity of 0.00% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Autonomix MedicalN/A -174.70% -133.35% Meihua International Medical Technologies N/A N/A N/A Which has more risk and volatility, AMIX or MHUA? Autonomix Medical has a beta of -2.99, meaning that its stock price is 399% less volatile than the S&P 500. Comparatively, Meihua International Medical Technologies has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Which has preferable valuation and earnings, AMIX or MHUA? Meihua International Medical Technologies has higher revenue and earnings than Autonomix Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutonomix MedicalN/AN/A-$11.41M-$7.47-0.19Meihua International Medical Technologies$96.90M0.14$10.84MN/AN/A Do analysts rate AMIX or MHUA? Autonomix Medical currently has a consensus price target of $16.50, suggesting a potential upside of 1,061.97%. Given Autonomix Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Autonomix Medical is more favorable than Meihua International Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Meihua International Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryMeihua International Medical Technologies beats Autonomix Medical on 6 of the 11 factors compared between the two stocks. Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMIX vs. The Competition Export to ExcelMetricAutonomix MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.98M$6.83B$5.61B$9.30BDividend YieldN/A1.21%4.23%4.03%P/E Ratio-0.1925.9728.5219.58Price / SalesN/A61.63426.1793.37Price / CashN/A20.3636.0257.93Price / Book0.434.638.135.54Net Income-$11.41M$174.76M$3.24B$257.73M7 Day Performance-5.96%-3.25%0.20%-0.08%1 Month Performance13.60%-0.33%5.98%8.09%1 Year Performance-93.30%0.36%26.15%13.02% Autonomix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMIXAutonomix Medical3.1471 of 5 stars$1.42-0.7%$16.50+1,062.0%-94.9%$3.98MN/A-0.191Positive NewsMHUAMeihua International Medical Technologies1.3191 of 5 stars$0.41-1.7%N/A-51.9%$13.00M$96.91M0.00620Positive NewsGap UpLYRALyra Therapeutics2.6704 of 5 stars$9.13+1.1%$100.00+995.3%-44.4%$12.14M$1.53M-0.1550News CoverageAnalyst DowngradeINBSIntelligent Bio Solutions0.8873 of 5 stars$1.71+0.6%N/A-1.6%$11.82M$2.94M0.0010News CoveragePositive NewsGap UpWOKWORK Medical Technology GroupN/A$0.80+12.6%N/AN/A$11.67M$11.51M0.00226Positive NewsDHAIDIH Holding US0.6694 of 5 stars$0.24-3.5%N/A-92.3%$11.24M$64.47M-0.79N/ANews CoveragePositive NewsGap DownSSKNStrata Skin Sciences3.3131 of 5 stars$2.39+0.4%$6.00+151.0%-24.8%$9.97M$33.62M-1.05120PAVMPAVmed4.3811 of 5 stars$0.58-2.5%$19.00+3,204.3%-39.0%$9.83M$2.99M0.8190Positive NewsBTCYBiotricityN/A$0.39+6.9%N/A-53.1%$9.59M$12.06M-0.3640Gap DownCODXCo-Diagnostics4.1189 of 5 stars$0.28+7.4%$5.50+1,862.2%-79.2%$9.41M$3.91M-0.24100News CoveragePositive NewsNURONeuroMetrixN/A$4.55+4.4%N/A+23.3%$9.37M$3.03M-0.9920High Trading Volume Related Companies and Tools Related Companies Meihua International Medical Technologies Competitors Lyra Therapeutics Competitors Intelligent Bio Solutions Competitors WORK Medical Technology Group Competitors DIH Holding US Competitors Strata Skin Sciences Competitors PAVmed Competitors Biotricity Competitors Co-Diagnostics Competitors NeuroMetrix Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMIX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMIX Stock Alerts